DMSO Toxicity Study

This detailed survey will utilise the wide variation in centre practice to prospectively define the rate of DMSO complications and to see if a strategy to reduce DMSO administration to patients can reduce the incidence of these complications.

The EBMT decided that in general for this observational audit, no ethical approval is necessary, but this could differ per centre. Please contact your EC in case of any doubts.

A patient consent form should be collected for this observational audit because we collect additional data which is not in the standard EBMT MED A/B forms.

Word forms are available on request from the data office in Leiden.

Background and Outline
Letter of Invitation
Registration Form
Centre Strategy for DMSO Use
Stem Cell Administration
Side Effects and Complications
Patient Consent Form	eng deit nl fr

For further information please contact :

EBMT Clinical Trials and Study Office - Leiden
Department of Medical Statistics & Bioinformatics
Postzone S-05-P LUMC
PO Box 9600 2300 RC
Leiden
The Netherlands

Email: clwpebmt@lumc.nl

Tel: +31-71-526 9724
Fax:+49-711-4900-8723